Online citations, reference lists, and bibliographies.
← Back to Search

Practice Parameter Update: The Care Of The Patient With Amyotrophic Lateral Sclerosis: Multidisciplinary Care, Symptom Management, And Cognitive/behavioral Impairment (an Evidence-based Review)

R. Miller, C. Jackson, E. Kasarskis, J. England, D. Forshew, W. Johnston, S. Kalra, J. Katz, H. Mitsumoto, J. Rosenfeld, C. Shoesmith, M. Strong, S. Woolley
Published 2009 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Objective: To systematically review evidence bearing on the management of patients with amyotrophic lateral sclerosis (ALS). Methods: The authors analyzed studies from 1998 to 2007 to update the 1999 practice parameter. Topics covered in this section include breaking the news, multidisciplinary clinics, symptom management, cognitive and behavioral impairment, communication, and palliative care for patients with ALS. Results: The authors identified 2 Class I studies, 8 Class II studies, and 30 Class III studies in ALS, but many important areas have been little studied. More high-quality, controlled studies of symptomatic therapies and palliative care are needed to guide management and assess outcomes in patients with ALS. Recommendations: Multidisciplinary clinic referral should be considered for managing patients with ALS to optimize health care delivery and prolong survival (Level B) and may be considered to enhance quality of life (Level C). For the treatment of refractory sialorrhea, botulinum toxin B should be considered (Level B) and low-dose radiation therapy to the salivary glands may be considered (Level C). For treatment of pseudobulbar affect, dextromethorphan and quinidine should be considered if approved by the US Food and Drug Administration (Level B). For patients who develop fatigue while taking riluzole, withholding the drug may be considered (Level C). Because many patients with ALS demonstrate cognitive impairment, which in some cases meets criteria for dementia, screening for cognitive and behavioral impairment should be considered in patients with ALS (Level B). Other management strategies all lack strong evidence.
This paper references
10.1111/j.1600-0404.1986.tb03510.x
Neuropsychological measures in amyotrophic lateral sclerosis and their relationship with CT scan‐assessed cerebral atrophy
M. Poloni (1986)
10.1056/NEJM199403033300901
A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group.
G. Bensimon (1994)
10.1016/0022-510X(95)00154-T
Prognosis of amyotrophic lateral sclerosis and the effect of referral selection
Ju Ruey-Jiuan Lee (1995)
10.1016/S0140-6736(96)91680-3
Dose-ranging study of riluzole in amyotrophic lateral sclerosis
Amyotrophic Lateral SclerosisRiluzole Study Group (1996)
Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II.
L. Lacomblez (1996)
Dose-ranging study of riluzole in amyotrophic lateral sclerosis: Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet 1996;347:1425–1431
L Lacomblez (1996)
10.1016/S0303-8467(97)80001-7
Relation of neuropsychological and magnetic resonance findings in amyotrophic lateral sclerosis: evidence for subgroups
B. Frank (1997)
10.1212/WNL.51.6.1546
Frontotemporal lobar degeneration
D. Neary (1998)
10.1016/S0022-510X(98)00211-1
Breaking the news in amyotrophic lateral sclerosis
G. Borasio (1998)
10.1136/jnnp.65.6.881
Dementia and aphasia in motor neuron disease: an underrecognised association?
W. Rakowicz (1998)
Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51:1546–1554
D Neary (1998)
10.1212/WNL.53.5.1158-b
Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria.
Rudolf Faber (1999)
10.1016/S0022-510X(99)00214-2
Pathological laughing and crying in amyotrophic lateral sclerosis: an association with prefrontal cognitive dysfunction
S. McCullagh (1999)
10.1212/WNL.52.7.1311
Practice parameter: The care of the patient with amyotrophic lateral sclerosis (an evidence-based review)
R.G. Miller (1999)
10.1177/154596839901300202
Practice Parameter: The Care of the Patient with Amyotrophic Lateral Sclerosis (An Evidence-Based Review): Report of the Quality Standards Subcommittee of the American Academy of Neurology
R. Miller (1999)
: ALS Practice Parameters Task Force
L McCluskey (1999)
10.1016/S0022-510X(01)00610-4
The value of muscle exercise in patients with amyotrophic lateral sclerosis
V. Drory (2001)
10.2310/7070.2001.19779
Use of radiotherapy for control of sialorrhea in patients with amyotrophic lateral sclerosis.
M. Harriman (2001)
10.1212/WNL.57.3.500
Current management of ALS
W. Bradley (2001)
10.1212/WNL.56.7.843
Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis
R. Miller (2001)
10.1016/S0022-510X(01)00631-1
External radiation of the parotid glands significantly reduces drooling in patients with motor neurone disease with bulbar paresis
P. Andersen (2001)
10.1080/146608201300079364
A double-blind, placebo-controlled randomized clinical trial of α-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis
C. Desnuelle (2001)
A double - blind , placebo - controlled randomized clinical trial of alpha - tocopherol ( vitamin E ) in the treatment of amyotrophic lateral sclerosis
C Desnuelle (2001)
10.1046/J.1468-1331.2002.0090S1030.X
The medical management of spasticity.
G. Abbruzzese (2002)
10.1212/01.WNL.0000055861.95202.8D
Are amyotrophic lateral sclerosis patients cognitively normal?
C. Lomen-Hoerth (2003)
10.1136/jnnp.74.9.1258
Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996–2000
B. Traynor (2003)
10.1080/14660820310017344
A survey of clinicians' practice in the symptomatic treatment of ALS.
D. Forshew (2003)
Effects of a multidisciplinary ALS clinic on survival
BJ Traynor (2003)
Are amyotrophic lateral sclerosis patients cognitively normal? Neurology 2003;60:1094–1097
C Lomen-Hoerth (2003)
10.1080/14660820410021249
Changes in the management of ALS since the publication of the AAN ALS practice parameter 1999
W. Bradley (2004)
10.1080/14660820410020772
Breaking the news: A survey of ALS patients and their caregivers
L. McCluskey (2004)
10.1212/01.WNL.0000142042.50528.2F
Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine
B. Brooks (2004)
10.1007/s00702-004-0220-1
High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study
M. Graf (2004)
10.1212/01.wnl.0000172911.39167.b6
Prevalence and patterns of cognitive impairment in sporadic ALS
G. Ringholz (2005)
10.1212/01.wnl.0000180717.29273.12
Multidisciplinary ALS care improves quality of life in patients with ALS
J. van den Berg (2005)
[Pharmacological therapy of sialorrhea in patients with motor neuron disease].
G. N. Levitskiĭ (2005)
10.1111/j.1468-1331.2005.01351.x
EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives
P. Andersen (2005)
10.1212/01.wnl.0000167187.14501.0c
Prevalence of depressive disorders and change over time in late-stage ALS
J. Rabkin (2005)
10.1136/jnnp.2005.083402
Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities
A. Chiò (2006)
10.1136/jnnp.2005.073403
Cognitive functioning in sporadic amyotrophic lateral sclerosis: a six month longitudinal study
K. Robinson (2006)
Drug products withdrawn from sale for reasons other than safety or effectiveness : quinine - containing drug products ; enforcement action dates
VE Drory (2006)
10.1212/01.WNL.0000281904.21495.CB
Effect of referral bias on assessing survival in ALS.
E. Sorenson (2007)
ALS multidisciplinary clinic and survival. Results from a population-based study in Southern Italy.
S. Zoccolella (2007)
10.1001/ARCHNEUR.64.4.530
Continuum of frontal lobe impairment in amyotrophic lateral sclerosis.
J. M. Murphy (2007)
10.2165/00023210-200721040-00003
Depression and Anxiety in Individuals with Amyotrophic Lateral Sclerosis
A. Kurt (2007)
10.1097/01.wco.0000280411.57836.aa
Treatment of sialorrhoea in patients with Parkinson's disease: best current evidence
L. Molloy (2007)
Depression and anxiety in individuals with amyotrophic lateral sclerosis: epidemiology and management. CNS Drugs 2007;21:279–291
A Kurt (2007)
Depression and anxiety in individuals with amyotrophic lateral sclerosis: epidemiology and management
A Kurt (2007)
Depression and anxiety in individuals with amyotrophic lateral sclerosis : epidemiology and management
JG Rabkin (2007)
Subcommittee of the American Academy of Neurology
M. Naumann (2008)
Randomized double - blind study of botulinum toxin type B for sialor - rhea in ALS patients
CE Jackson (2008)
Randomized double-blind study of botulinum toxin type B for sialorrhea in ALS patients. Muscle Nerve 2008;39:137–143
CE Jackson (2008)
10.1093/annonc/mdn709
The process of truth disclosure: an assessment of the results of information during the diagnostic phase in patients with cancer.
G. Numico (2009)
10.1007/BF03160565
Sleep in patients with amyotrophic lateral sclerosis
J. Hetta (2009)
10.1002/mus.21213
Randomized double‐blind study of botulinum toxin type B for sialorrhea in als patients
C. Jackson (2009)
Endorsed by the American Academy of Neuromuscular and Electrodiagnostic Medicine
(2009)
Endorsed by the American Academy of Neuromuscular and Electrodiagnostic Medicine
(2009)
tables) or in its entirety can be found online at: Information about reproducing this article in parts (figures



This paper is referenced by
10.1212/NXG.0000000000000615
Amyotrophic Lateral Sclerosis Genetic Access Program
J. Roggenbuck (2021)
10.3988/jcn.2021.17.3.463
Validation of the Korean version of the Boston Autonomic Symptom Questionnaire
E. Sohn (2021)
10.1016/j.arr.2020.101209
Emerging potential of cannabidiol in reversing proteinopathies
R. Dash (2021)
10.7759/cureus.16297
Acute on Chronic Neuromuscular Respiratory Failure in the Intensive Care Unit: Optimization of Triage, Ventilation Modes, and Extubation
Nick M. Murray (2021)
10.1007/s10072-020-05011-2
Multidisciplinary care in Amyotrophic Lateral Sclerosis: a systematic review and meta-analysis
Filipe Emanuel Oliveira de Almeida (2021)
10.3233/JND-210687
Healthcare Utilisation and Satisfaction with Care in Patients with Amyotrophic Lateral Sclerosis - An Observational Study.
M. Kierkegaard (2021)
10.1007/978-3-030-71478-9_9
Parkinson’s Disease and Future Trends in Telemedicine
Tejas Mehta (2021)
10.1080/21678421.2020.1867180
Problem-focused coping underlying lower caregiver burden in ALS-FTD: implications for caregiver intervention
J. Caga (2021)
10.3390/nu13072273
Metabolic Abnormalities, Dietary Risk Factors and Nutritional Management in Amyotrophic Lateral Sclerosis
E. D’Amico (2021)
10.1007/s13691-021-00499-7
Robot-assisted total gastrectomy for gastric cancer in a patient with amyotrophic lateral sclerosis receiving long-term tracheostomy invasive ventilation
M. Nishi (2021)
10.3389/fpsyg.2021.752461
Practical Measures for Dealing With the Struggles of Nurses Caring for People With Amyotrophic Lateral Sclerosis Comorbid With Cognitive Impairment in Japan
M. Ushikubo (2021)
10.1016/j.nmd.2020.11.001
Dysphagia in adult myopathies
Z. Argov (2021)
10.1136/bmjspcare-2020-002741
People with amyotrophic lateral sclerosis and their caregivers: what matters most?
P. Brunori (2021)
10.1155/2021/5537892
The Evaluation of Pain with Nociceptive and Neuropathic Characteristics from Three Different Perspectives in Amyotrophic Lateral Sclerosis Patients: A Case Controlled Observational Study in Southwestern China
Ran An (2021)
10.1080/21678421.2021.1924206
The relationship between ventilatory function and cognitive and behavioral impairment in ALS
Jaimin S Shah (2021)
10.3389/fneur.2021.740693
Illness Cognitions in ALS: New Insights Into Clinical Management of Behavioural Symptoms
J. Caga (2021)
10.1016/j.nrleng.2020.12.001
Impact of the COVID-19 pandemic on a cohort of ALS patients in Catalonia☆
B. Bertran Recasens (2021)
FACTORS AFFECTING THE LENGTH OF STAY IN AMYOTROPHIC LATERAL SCLEROSIS IN PALLIATIVE CARE
(2021)
10.1080/21678421.2021.1936064
Caregivers' divergent perspectives on patients' well-being and attitudes towards hastened death in Germany, Poland and Sweden.
P. Andersen (2021)
10.1016/j.jpainsymman.2021.03.008
The Palliative Care information needs of patients with amyotrophic lateral sclerosis and their informal caregivers: a scoping review.
Jacqueline Gillespie (2021)
10.1080/21678421.2021.1910307
Use of a new ALS specific respiratory questionnaire: the ARES score
T. Heiman-Patterson (2021)
10.1016/j.pmr.2020.12.003
Telehealth for Amyotrophic Lateral Sclerosis and Multiple Sclerosis.
I. Howard (2021)
10.1080/21678421.2021.1874991
Delivery of nutritional management services to people with amyotrophic lateral sclerosis (ALS)
V. Halliday (2021)
The development of palliative care for people with progressive neurological disease
D. Oliver (2020)
10.1038/s41598-020-70422-2
Predictive factors for prognosis after gastrostomy placement in routine non-invasive ventilation users ALS patients
A. Hesters (2020)
10.1212/NXG.0000000000000542
C9orf72 and the Care of the Patient With ALS or FTD
J. Roggenbuck (2020)
High Frequency Chest Wall Compression Devices (for Tennessee Only) – Community Plan Medical Policy
(2020)
10.17345/AEC21.37-68
The ‘way of flowers’ and the care of patients with amyotrophic lateral sclerosis in Japan
Y. Himeno (2020)
High Frequency Chest Wall Compression Devices – Community Plan Medical Policy
(2020)
10.1503/cmaj.191721
Canadian best practice recommendations for the management of amyotrophic lateral sclerosis
C. Shoesmith (2020)
10.1212/WNL.0000000000010831
Models of outpatient neuropalliative care for patients with amyotrophic lateral sclerosis
Joel N Phillips (2020)
10.1007/s11940-020-00640-6
Management of Primary Lateral Sclerosis
CuiPing Zhao (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar